北京海润天睿律师事务所 关于三未信安科技股份有限公司 作废 2023 年限制性股票激励计划部分限制性股票及 2024 年限制性股票激励计划预留授予部分 第一个归属期归属条件成就的 法律意见书 中国·北京 北京市朝阳区建外大街甲14号广播大厦5/9/10/13/17层 邮政编码：100022 电话(Tel):86-10-65219696 传真(Fax):86-10-88381869 北京海润天睿律师事务所 关于三未信安科技股份有限公司 作废 2023 年限制性股票激励计划部分限制性股票及 为出具本法律意见书，本所及经办律师作出如下声明： （一）在出具本法律意见书过程中，本所已得到公司如下保证：就本所认为出 具法律意见书所必需审查的事项而言，公司已经提供了全部相关的原始书面材料、 副本材料，有关副本材料或者复印件与原件一致；文件中的盖章及签字全部真实； 提供的文件以及有关口头陈述均真实、准确和完整，且不包含任何误导性的信息； 一切足以影响本激励计划的事实和文件均已向本所披露，且无任何隐瞒、疏漏之处。 （二）本所及经办律师依据《证券法》《律师事务所从事证券法律业务管理办 法》和《律师事务所证券法律业务执业规则》等规 ...

三未信安科技股份有限公司 2025 年第三季度报告 证券代码：688489 证券简称：三未信安 三未信安科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 1 / 12 单位：元 币种：人民币 项目 本报告期 本报告期比 上年同期增 减变动幅度 (%) 年初至报告期末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 99,763,378.77 16.91 294,810,040.96 15.76 利润总额 -16,768,935.64 不适用 -59,984,622.55 -1298.84 归属于上市公司股东的 净利润 -9,7 ...

Core Insights - He Yuan Bio became the first project to be approved after the resumption of the fifth set of standards on the Sci-Tech Innovation Board, officially listing on October 28 [1] - The investment firm Yifeng Capital has been supporting He Yuan Bio for over nine years since its investment in 2016, focusing on the development of innovative drugs in the medical health sector [1][2] - Yifeng Capital's CEO, Zhu Pai, emphasizes the importance of value investment and patience in supporting companies through various cycles, particularly in the context of China's pharmaceutical industry [1][6] Company Development - He Yuan Bio has developed a recombinant human serum albumin extraction technology from rice, successfully transitioning from pilot production to commercialization [2][3] - The company faced significant challenges during its industrialization phase, including financial pressure and sales difficulties, which are common in the "valley of death" for tech startups [2][3] - After nine years of support, He Yuan Bio achieved significant milestones, including the approval of its core product in July 2025 and its listing on the Sci-Tech Innovation Board in October [3] Investment Strategy - Yifeng Capital has invested in over a hundred projects, focusing on innovative drugs and high-end medical devices, avoiding investments in heavy asset hospitals and ordinary consumables [4][5] - The firm employs a professional team with extensive experience in the medical field, enabling it to identify trends and assess project value effectively [4] - Zhu Pai outlines three key dimensions for selecting investment projects: technological and clinical progress, innovation in drug formulation, and sustained R&D capabilities [5] Industry Trends - The Chinese pharmaceutical industry is experiencing a surge in collaboration with major global pharmaceutical companies, leading to explosive growth in overseas licensing deals [6] - Chinese pharmaceutical companies are increasingly recognized in the global market, enhancing their competitiveness and profitability through international expansion [6] - Yifeng Capital remains optimistic about the long-term development opportunities in the Chinese pharmaceutical sector, focusing on value investment and supporting companies in their R&D breakthroughs [6]

● 股东持有的基本情况 本次减持计划实施前，北京立达高新创业投资中心（有限合伙）（以下简称"立达高新"）持有三未信安 科技股份有限公司（以下简称"三未信安"或"公司"）9,000,000股，占公司披露减持计划时股份总数的 7.84%。以上股份来源于公司首次公开发行前取得的股份及公司实施资本公积金转增股本取得的股份， 且于2023年12月4日上市流通。 证券代码：688489 证券简称：三未信安 公告编号：2025-071 三未信安科技股份有限公司关于持股5%以上股东减持计划时间届满暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 披露的减持时间区间届满 ■ ● 减持计划的实施结果情况 2025年7月3日，公司在上海证券交易所网站（www.sse.com.cn）及指定媒体披露了《股东减持股份计划 公告》（公告编号：2025-056）。公司5%以上股东立达高新持有公司股份9,000,000股，占公司披露减 持计划时股份总数的7.84%，拟通过集中竞价方式或大宗交易方式减持其所持有的公 ...

Market Overview - On October 24, the computer equipment sector rose by 2.05%, led by Aerospace Intelligence [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance - Aerospace Intelligence (300455) saw a closing price of 19.76 with a significant increase of 19.98% and a trading volume of 311,100 shares, amounting to a transaction value of 614 million [1] - Weihong Co., Ltd. (300508) closed at 31.98, up 12.61%, with a trading volume of 94,300 shares [1] - Dahua Intelligent (002512) closed at 4.46, up 10.12%, with a trading volume of 672,500 shares [1] - Other notable performers include Langke Technology (300042) with an 8.93% increase and a closing price of 33.18, and Jiayuan Technology (301117) with a 7.96% increase and a closing price of 43.25 [1] Capital Flow - The computer equipment sector experienced a net inflow of 1.494 billion in main funds, while retail funds saw a net outflow of 575 million [2] - The main funds' net inflow for Zhongke Shuguang (603019) was 914 million, accounting for 12.96% of the total, while retail funds had a net outflow of 578 million [3] - Dahua Intelligent (002512) had a main fund net inflow of 139 million, representing 46.50% of the total, with retail funds experiencing a net outflow of 64.93 million [3]

南财智讯10月24日电，三未信安公告，北京立达高新创业投资中心（有限合伙）作为公司持股5%以上 的股东，自2025年7月24日至2025年10月23日期间，通过集中竞价方式减持122.78万股，占公司总股本 的1.07%，减持总金额为6394.05万元。减持后，立达高新的持股比例降至6.75%。 ...

证券代码：688489 证券简称：三未信安 公告编号：2025-071 三未信安科技股份有限公司 减持计划的实施结果情况 2025 年 7 月 3 日，公司在上海证券交易所网站（www.sse.com.cn）及指定 媒体披露了《股东减持股份计划公告》（公告编号：2025-056）。公司 5%以上 股东立达高新持有公司股份 9,000,000 股，占公司披露减持计划时股份总数的 7.84%，拟通过集中竞价方式或大宗交易方式减持其所持有的公司股份数量不超 2,295,370 股，即不超过披露减持计划时公司股份总数的 2.00%。截至 2025 年 10 月 23 日，立达高新已通过集中竞价方式减持公司股份 1,227,820 股，占公司 目前总股本的 1.07%。立达高新于 2025 年 10 月 23 日减持 433,775 股，当日持 股比例由 7.12%减持至 6.75%，股东权益变动触及 1%刻度。 一、减持主体减持前基本情况 | 股东名称 | 北京立达高新创业投资中心（有限合伙） | | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 □是 √否 直接持股 √是 □否 5%以上股 ...

Core Points - The major shareholder, Lida Gaoxin, has completed its share reduction plan, which was initially announced on July 3, 2025 [1] - Lida Gaoxin originally held 9 million shares, representing 7.84% of the company, and the shares became tradable on December 4, 2023 [1] - As of October 23, Lida Gaoxin has reduced its holdings by 1.07% of the total share capital, amounting to 1.2278 million shares, with a total reduction value of approximately 63.94 million yuan [1] - The reduction price ranged from 42.24 to 59.30 yuan per share, leaving 1.0676 million shares yet to be sold, resulting in a current holding percentage of 6.75% [1]

Group 1 - The core viewpoint of the news is that Sanwei Xinan's stock price increased by 5.4% to 52.92 CNY per share, with a total market capitalization of 6.097 billion CNY as of the report date [1] - Sanwei Xinan Technology Co., Ltd. specializes in the innovation of cryptographic technology and the development, sales, and services of cryptographic products, providing comprehensive commercial cryptographic products and solutions for the network information security field [1] - The company's main business revenue composition includes: cryptographic machines 44.79%, cryptographic systems 26.19%, cryptographic services and others 22.67%, cryptographic modules 4.40%, security systems and network security products 0.71%, others (supplementary) 0.65%, and cryptographic chips 0.58% [1] Group 2 - Among the top ten circulating shareholders of Sanwei Xinan, a fund under Southern Fund has increased its holdings by 216,200 shares, bringing its total to 926,900 shares, which accounts for 1.83% of the circulating shares [2] - The Southern Science and Technology Innovation Board 3-Year Open Mixed Fund (506000) has achieved a return of 37.58% this year, ranking 1796 out of 8159 in its category, and a return of 42.53% over the past year, ranking 1152 out of 8030 [2] - The fund manager, Zheng Xiaoxi, has a total fund asset scale of 5.844 billion CNY, with the best fund return during his tenure being 149.86% and the worst being -33.69% [3]

Core Viewpoint - The U.S. government, led by President Trump, announced a 100% tariff on all Chinese goods starting November 1, along with export controls on key software, which will accelerate the domestic software replacement process in China [2][3]. Group 1: U.S. Trade Measures - The U.S. will impose a 100% additional tariff on all Chinese imports and export controls on key software starting November 1 [2]. - The U.S. measures are seen as a strategic move to pressure China ahead of the APEC summit, with potential implications for negotiations [2][3]. Group 2: China's Response and Industry Impact - China's Ministry of Commerce has implemented export controls on various technologies, including chip production equipment and lithium batteries, which are crucial for modern industries [2][3]. - China is expected to dominate the rare earth industry by 2025, holding 49% of global reserves and 69% of production, making it a critical resource for the U.S. [2][3]. Group 3: Domestic Software Development - The export controls on key software will accelerate the domestic replacement process in China, particularly in the fields of EDA, CAD, CAE, MES, and PLM [3][4]. - The shift towards domestic software is seen as essential due to China's heavy reliance on imported industrial software [3][4]. Group 4: Industrial Digital Transformation - The announcement of using WPS format in government documents marks a significant milestone for domestic software, indicating a breakthrough in the software replacement strategy [4]. - "Lighthouse factories," which utilize advanced technologies for efficiency, are expected to be prioritized in national strategic development plans, driving demand for industrial software [4]. Group 5: Investment Opportunities - Companies in the EDA, industrial software, operating systems, databases, network security, and industry IT sectors are highlighted as potential investment opportunities due to the ongoing shift towards domestic solutions [4]. - Specific companies to watch include: - EDA: Huada Jiutian, Guangliwei, Gai Lun Electronics [4] - Industrial Software: Dingjie Zhizhi, Nengke Technology, Suochen Technology, Zhongwang Software, Zhongkong Technology [4] - Operating Systems: China Software, Ruantong Power, Runhe Software, Chengmai Technology [4] - Databases: Dameng Data, Taiji Co. [4] - Network Security: Deepin Technology, Qilin Security, Sanwei Security, Guotou Intelligent, Qimingxing Chen [4] - Industry IT: Keda Xunfei, Hehe Information, Hengsheng Electronics, Kingsoft Office, Foxit Software, Tuolisi, Tax Friend Shares, Caixun Shares, Dingdian Software, Jiuyuan Yinhai, Jiahe Meikang, Guanglian Da, Kingdee International, Yonyou Network, Fanwei Network, Yuxin Technology, Newland [4].